APA (7th ed.) Citation

Aapro, M. S., Jordan, K., Scotté, F., Celio, L., Karthaus, M., & Roeland, E. (2022). Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting: From clinical trials to daily practice. Current cancer drug targets, 22(10), . https://doi.org/10.2174/1568009622666220513094352

Chicago Style (17th ed.) Citation

Aapro, Matti S., Karin Jordan, Florian Scotté, Luigi Celio, Meinolf Karthaus, and Eric Roeland. "Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice." Current Cancer Drug Targets 22, no. 10 (2022). https://doi.org/10.2174/1568009622666220513094352.

MLA (9th ed.) Citation

Aapro, Matti S., et al. "Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice." Current Cancer Drug Targets, vol. 22, no. 10, 2022, https://doi.org/10.2174/1568009622666220513094352.